Inhibition of Smooth Muscle Cell Proliferation by Ezetimibe via the Cyclin D1-MAPK Pathway
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of Smooth Muscle Cell Proliferation by Ezetimibe via the Cyclin D1-MAPK Pathway
Authors
Keywords
-
Journal
JOURNAL OF PHARMACOLOGICAL SCIENCES
Volume 125, Issue 3, Pages 283-291
Publisher
Japanese Pharmacological Society
Online
2014-07-19
DOI
10.1254/jphs.13239fp
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ezetimibe Inhibits Hepatic Niemann-Pick C1-Like 1 to Facilitate Macrophage Reverse Cholesterol Transport in Mice
- (2013) Ping Xie et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Ezetimibe Therapy for Dyslipidemia: An Update
- (2013) Niki Katsiki et al. CURRENT PHARMACEUTICAL DESIGN
- Antitumor activity of novel chimeric peptides derived from cyclinD/CDK4 and the protein transduction domain 4
- (2012) Haili Wang et al. AMINO ACIDS
- Dietary Cholesterol Oxidation Products Accelerate Plaque Destabilization and Rupture Associated with Monocyte Infiltration/Activation via the MCP-1-CCR2 Pathway in Mouse Brachiocephalic Arteries: Therapeutic Effects of Ezetimibe
- (2012) Kei Sato et al. Journal of Atherosclerosis and Thrombosis
- Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
- (2012) Andreas Engert et al. LANCET
- Alpha-lipoic acid attenuates atherosclerotic lesions and inhibits proliferation of vascular smooth muscle cells through targeting of the Ras/MEK/ERK signaling pathway
- (2012) Woo-Ram Lee et al. MOLECULAR BIOLOGY REPORTS
- Inhibitory Effects of Cilostazol on Proliferation of Vascular Smooth Muscle Cells (VSMCs) Through Suppression of the ERK1/2 Pathway
- (2011) A Rum Yoo et al. Journal of Atherosclerosis and Thrombosis
- Ezetimibe and Vascular Inflammation
- (2010) Toshiyuki Ishibashi et al. Current Vascular Pharmacology
- Pleiotropic effects of ezetimibe: Do they really exist?
- (2010) Michalis Kalogirou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cholesterol Inhibits M-type K+Channels via Protein Kinase C-dependent Phosphorylation in Sympathetic Neurons
- (2010) Seul-Yi Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Static pressure drives proliferation of vascular smooth muscle cells via caveolin-1/ERK1/2 pathway
- (2009) Di-xian Luo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect
- (2009) D Gómez-Garre et al. BRITISH JOURNAL OF PHARMACOLOGY
- Control of cell proliferation in atherosclerosis: insights from animal models and human studies
- (2009) J. J. Fuster et al. CARDIOVASCULAR RESEARCH
- Specific phosphorylation and activation of ERK1c by MEK1b: a unique route in the ERK cascade
- (2009) Y. D. Shaul et al. GENES & DEVELOPMENT
- Vascular protective effects of ezetimibe in ApoE-deficient mice
- (2008) Hironori Nakagami et al. ATHEROSCLEROSIS
- Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells
- (2008) Li Qin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effects and underlying mechanisms of curcumin on the proliferation of vascular smooth muscle cells induced by Chol:MβCD
- (2008) Li Qin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effects of Rosiglitazone on the Proliferation of Vascular Smooth Muscle Cell Induced by High Glucose
- (2008) Hong-Yan Ling et al. CARDIOVASCULAR DRUGS AND THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started